Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer

Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer

ABSTRACT Objective Chemotherapy-induced nausea and vomiting are highly prevalent adverse events that can lead to poor treatment adherence and a decreased quality of life. To the best of our knowledge, the complete omission of dexamethasone from any regimen for preventing nausea and vomiting has no...

Full description

Saved in:
Bibliographic Details
Main Authors: Camilla Vieira de Rebouças, Rafaela de Brito Alves, Alayne Magalhães Trindade Domingues Yamada, Auro del Giglio, Felipe José Silva Melo Cruz
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2025-05-01
Series:Einstein (São Paulo)
Subjects:
Dexamethasone
Drug therapy
Nausea
Olanzapine
Vomiting
Breast neoplasms
Antineoplastic agents
Drug-related side effects and adverse reactions
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082025000100225&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items